SMARCA4 inactivating mutations cause concomitant Coffin–Siris syndrome, microphthalmia and small‐cell carcinoma of the ovary hypercalcaemic type

SMARCA4 chromatin remodelling factor is mutated in 11% of Coffin–Siris syndrome (CSS) patients and in almost all small‐cell carcinoma of the ovary hypercalcaemic type (SCCOHT) tumours. Missense mutations with gain‐of‐function or dominant‐negative effects are associated with CSS, whereas inactivating...

Descripción completa

Detalles Bibliográficos
Autores principales: Errichiello, Edoardo, Mustafa, Noor, Vetro, Annalisa, Notarangelo, Lucia Dora, de Jonge, Hugo, Rinaldi, Berardo, Vergani, Debora, Giglio, Sabrina Rita, Morbini, Patrizia, Zuffardi, Orsetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Brief Definitive Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601212/
https://www.ncbi.nlm.nih.gov/pubmed/28608987
http://dx.doi.org/10.1002/path.4926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601212/
https://www.ncbi.nlm.nih.gov/pubmed/28608987
http://dx.doi.org/10.1002/path.4926

Ejemplares similares